Q4FY17 Results: Alembic Pharmaceuticals Ltd
Rohan Takalkar / 03 May 2017
Alembic Pharmaceuticals Ltd. reported its results for the quarter ended March 31, 2017 today.The company's total sales for Q4FY17 came in at Rs 736.5 crore, which represents a 4.33 per cent sequential decline and 18.96 per cent YoY increase.
Alembic Pharmaceuticals Ltd. reported its results for the quarter ended March 31, 2017 today.
The company's total sales for Q4FY17 came in at Rs 736.5 crore, which represents a 4.33 per cent sequential decline and 18.96 per cent YoY increase.
Its operating profit (EBIT) for the quarter was Rs 111.44 crore and its EBIT margin stood at 15.13 per cent.
The company reported PAT of Rs 95.33 crore, which represents a sequential QoQ increase of 12.96 per cent and a YoY increase of 4.44 per cent.
The company's stock opened for trading at Rs 619 on the BSE and declined 1.62 per cent to close at Rs.609.
Alembic Pharmaceuticals Ltd is an India-based integrated pharmaceutical company. The company’s business is divided into the following segments: active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract/collaborated research services.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.